aspirin has been researched along with natriuretic peptide, brain in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N; Loh, H; Memon, A | 1 |
| Hamm, CW; Heeschen, C; Lantelme, NH; Mitrovic, V; White, HD | 1 |
| Bosch, J; Gerstein, HC; Lonn, E; McQueen, MJ; Yusuf, S | 1 |
| Jug, B; Keber, I; Sabovic, M; Sebestjen, M | 1 |
| Bergmann, JF; Cohen-Solal, A; Duboc, D; Fulla, Y; Mahé, I; Meune, C; Mouly, S; Simoneau, G; Wahbi, K; Weber, S | 1 |
| McLachlan, CS; Mossop, P; Zhang, Z | 1 |
| Cable, G; Willerson, JT; Yeh, ET | 1 |
| Brey, RL; Buchsbaum, R; Christenson, RH; deFilippi, CR; Elkind, MS; Gross, R; Kronmal, RA; Levine, SR; Longstreth, WT; Mohr, JP; Seliger, SL; Thompson, JL; Tirschwell, DL | 1 |
| Jiang, R; Wang, L; Wu, J; Wu, Y; Yang, R; Zhang, W; Zhi, Y | 1 |
| Campo, G; Ceconi, C; Contoli, M; Guerzoni, F; Malagù, M; Napoli, N; Papi, A; Pavasini, R; Punzetti, S | 1 |
| Cook, NR; Everett, BM; Pradhan, AD; Ridker, PM | 1 |
| Grześk, G; Kasprzak, M; Kubica, A; Kubica, J; Obońska, K; Ostrowska, M; Stolarek, W; Wiciński, M | 1 |
| Dong, X; Wang, X; Wei, L; Yin, Z; Zhang, L; Zhou, H | 1 |
| Cook, NR; Everett, BM; Pradhan, AD; Ridker, PM; Srivastava, PK | 1 |
| Denegri, A; Lüscher, TF; Mach, F; Matter, CM; Muller, O; Obeid, S; Räber, L; Shahin, M; Weidmann, L; Yousif, N | 1 |
| Agewall, S; Atar, D; Clark, AL; Cleland, JGF; Frankenstein, L; Fröhlich, H; Goode, K; Grundtvig, M; Hole, T; Katus, HA; Kazmi, S; Rosenfeld, N; Täger, T | 1 |
| Chen, LL; Lu, WL; Tang, DD; Wang, JP; Wang, W; Yan, SR; Zhao, LH | 1 |
| Dohi, K; Fujimoto, N; Ichikawa, K; Imanaka-Yoshida, K; Izumi, D; Katsuta, K; Sakaguchi, S; Takafuji, M | 1 |
| Bahit, MC; Brainin, M; Brueckmann, M; Cronin, L; Diener, HC; Easton, JD; Granger, CB; Grauer, C; Kleine, E; Lopes, RD; Lyrer, P; Meyerhoff, J; Sacco, RL; Segura, T; Wachter, R | 1 |
9 trial(s) available for aspirin and natriuretic peptide, brain
| Article | Year |
|---|---|
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Topics: Acute Disease; Anticoagulants; Aspirin; Biomarkers; C-Reactive Protein; Drug Therapy, Combination; Follow-Up Studies; Heparin; Humans; Incidence; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Predictive Value of Tests; Risk; Risk Assessment; Syndrome; Tirofiban; Troponin T; Tyrosine | 2004 |
The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cost-Benefit Analysis; Diabetes Complications; Female; Heart Failure; Humans; Inflammation; Kidney Diseases; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Ramipril; Stroke; Ventricular Function, Left; Vitamin E | 2005 |
Clopidogrel is associated with a lesser increase in NT-proBNP when compared to aspirin in patients with ischemic heart failure.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiac Output, Low; Clopidogrel; Cross-Over Studies; Disease Progression; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Effects of aspirin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Aspirin; Clopidogrel; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prostaglandins; Ticlopidine | 2007 |
PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Atherosclerosis; Biomarkers; C-Reactive Protein; CD40 Ligand; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inflammation Mediators; Least-Squares Analysis; Male; Metabolic Syndrome; Middle Aged; Natriuretic Peptide, Brain; P-Selectin; Peptide Fragments; Pilot Projects; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; United States; Young Adult | 2009 |
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.
Topics: Aged; Anticoagulants; Aspirin; Biomarkers; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Treatment Outcome; Warfarin | 2013 |
Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Topics: Aged; Antioxidants; Aspirin; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Female; Humans; Incidence; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Sex Factors; Vitamin E | 2015 |
Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
Topics: Aged; Aspirin; Biomarkers; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Massachusetts; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Neoplasms; Peptide Fragments; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Troponin T; Vitamin E; Vitamins; Women's Health | 2016 |
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Topics: Administration, Oral; Age Factors; Aged; Aspirin; Atrial Fibrillation; Body Mass Index; Dabigatran; Double-Blind Method; Embolic Stroke; Female; Humans; Hypertension; Male; Middle Aged; Models, Cardiovascular; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Recurrence; Risk Factors | 2021 |
10 other study(ies) available for aspirin and natriuretic peptide, brain
| Article | Year |
|---|---|
Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Azetidines; Benzimidazoles; Benzylamines; Biphenyl Compounds; Coronary Disease; Europe; Heart Failure; Humans; Natriuretic Peptide, Brain; Perindopril; Prodrugs; Randomized Controlled Trials as Topic; Tetrazoles | 2003 |
A mechanistic interaction remains to be determined for elevated NTproBNP in heart failure patients receiving both an ACE inhibitor and aspirin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Disease Progression; Drug Antagonism; Drug Interactions; Heart; Heart Failure; Humans; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments | 2007 |
Effects of aspirin on the ERK and PI3K/Akt signaling pathways in rats with acute pulmonary embolism.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Fibrin Fibrinogen Degradation Products; Gene Expression Regulation; Natriuretic Peptide, Brain; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Troponin T | 2013 |
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD.
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Cause of Death; Creatinine; Disease Progression; Female; Heart Failure; Humans; Male; Myocardial Infarction; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Stroke; Troponin T | 2015 |
Acetylsalicylic acid resistance risk factors in patients with myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Aspirin; C-Reactive Protein; Drug Resistance; Female; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Risk Factors | 2015 |
Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Topics: Angiotensin II; Animals; Animals, Newborn; Aspirin; Atrial Natriuretic Factor; Calcineurin; Calcium; Calcium Signaling; Cardiovascular Agents; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; NFATC Transcription Factors; Phosphorylation; Stroke Volume; Ventricular Function, Left | 2016 |
Pre-existing treatment with aspirin or statins influences clinical presentation, infarct size and inflammation in patients with de novo acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Aspirin; Biomarkers; C-Reactive Protein; Coronary Angiography; Electrocardiography; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Stroke Volume; Troponin T; Ventricular Function, Left | 2019 |
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Chronic Disease; Female; Germany; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mortality; Multivariate Analysis; Natriuretic Peptide, Brain; Norway; Outpatients; Peptide Fragments; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Registries; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; United Kingdom | 2019 |
Clinical efficacy of ticagrelor combined with aspirin in patients with coronary heart disease angina pectoris and its effects on NT-ProBNP and CK-MB levels.
Topics: Adult; Aspirin; Coronary Disease; Creatine Kinase, MB Form; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ticagrelor | 2020 |
Myopericarditis After COVID-19 mRNA Vaccination.
Topics: Adverse Drug Reaction Reporting Systems; Aspirin; BNT162 Vaccine; C-Reactive Protein; COVID-19; Diuretics; Humans; Male; Middle Aged; Myocarditis; Natriuretic Peptide, Brain; RNA, Messenger; SARS-CoV-2; Vaccination | 2022 |